InsidersTradesSigma
Track the 海森药业 share price and the full management transaction log of the company, a listed equity based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 海森药业 has published 1 reports. Market capitalisation: €2.6bn. The latest transaction was reported on 30 December 2025 (Sale). Among the most active insiders: 胡康康. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
海森药业是一家在XSHE市场上市的医疗保健和制药公司。该公司专注于创新医药产品的开发和商业化。